TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN
NCT04128722
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Lingual Microcystic Lymphatic Malformations
Interventions
DRUG:
Sirolimus Oral Liquid Product 1mg/mL
Sponsor
University Hospital, Tours